You are here

AusPAR: Bevacizumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

11 March 2020
AusPAR Details
AusPAR
Active Ingredient
Bevacizumab
Product Name
Zirabev
Sponsor
Pfizer Australia Pty Ltd
Submission Number
PM-2018-03842-1-4
Submission Type
New biosimilar medicine
Decision
Approved
AusPAR Date
26 February 2020
Publication Date

11 March 2020